Ballentine Partners, LLC RCKT ROCKET PHARMACEUTICALS INC

Ownership history in Ballentine Partners, LLC  ·  4 quarters on record

AI Ownership Summary

Ballentine Partners, LLC reported ROCKET PHARMACEUTICALS INC (RCKT) in 4 quarterly 13F filings from 2025 Q3 through 2026 Q2. The latest visible filing shows RCKT at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this RCKT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Ballentine Partners, LLC's position in ROCKET PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

RCKT was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Ballentine Partners, LLC held RCKT — position size vs. price
% of Fund (quarterly)    RCKT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 70,405 -18,596 -20.9% 0.00% $241K 2026-07-17 $3.44
2026 Q1 REDUCED 8.8% -5.9% 89,001 -8,624 -8.8% 0.00% $319K 2026-05-14 $3.40
2025 Q4 ADDED 97,625 +9,055 +10.2% 0.00% $343K 2026-02-03 $3.46
2025 Q3 INITIATED 88,570 0.00% $289K 2025-11-03 $3.56

FAQ About Ballentine Partners, LLC and RCKT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Ballentine Partners, LLC reported owning RCKT?

Ballentine Partners, LLC reported RCKT across 4 quarterly 13F filings, from 2025 Q3 through 2026 Q2.

What was the largest reported RCKT position in Ballentine Partners, LLC's portfolio?

The largest reported portfolio weight for RCKT was 0.00% in 2025 Q4.

What is the latest reported RCKT position on this page?

The most recent filing on this page is 2026 Q2, when Ballentine Partners, LLC reported 70,405 shares, equal to 0.00% of portfolio, with an estimated market value of $241K.

What does the chart on this RCKT ownership page compare?

The chart compares Ballentine Partners, LLC's quarterly RCKT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Ballentine Partners, LLC time their RCKT position?

Based on 13F filing dates vs. subsequent RCKT price moves, Ballentine Partners, LLC correctly timed 0 out of 3 reported position changes (0%). The annualised alpha on RCKT relative to SPY over the holding period was -16.5%.

← Back to Ballentine Partners, LLC Holdings